Marlborough biotech firm Advanced Cell Technology said it has picked up $30 million in capital through a common stock purchase agreement with a Chicago-based investment firm. The deal, with Lincoln ...

It’s only October, and Oregon already has its first conference championship haul of the year. The Ducks’ men’s and women’s cross country... WASHINGTON (KRT) ­ A Massachusetts company said Sunday that ...

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. Stem cell plays have cooled their jets since the news of Geron and Advanced Cell Technology becoming the first ...

In these days of rampant science phobia, a researcher associated with human cloning risks being linked to the few renegade scientists claiming to already have done the deed. Mike West's quest as ...

For only the second time, the Food and Drug Administration approved a company’s request to test an embryonic stem cell-based therapy on human patients. Advanced Cell Technology (ACT), based in ...

LOS ANGELES (Reuters) - Biotechnology company Advanced Cell Technology Inc. plans to publish in the first half of this year data from trials in animals of its stem cell-based therapies for macular ...

Losses at Advanced Cell Technology (ACT) of Marlborough deepened in its first quarter, as the cost of clinical trials for its macular degeneration treatments rose, the company said. Advanced Cell ...

Advanced Cell Technology Inc. wins $25 million commitment from investment firm Socius Capital Group. Advanced Cell Technology Inc. (OTC:ACTC) secured a $25 million investment to support clinical ...